Asset Details
Do you wish to reserve the book?
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
Do you wish to request the book?
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
2018
Overview
The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression. Compared to first-in-class Hsp90 inhibitors such as 17-allylamino-demethoxygeldanamycin (17-AAG) that were clinically ineffective, second generation inhibitor AUY922 has greater solubility and efficacy. Here, transcriptomic and proteomic analyses of patient-derived PCa explants identified cytoskeletal organization as highly enriched with AUY922 treatment. Validation in PCa cell lines revealed that AUY922 caused marked alterations to cell morphology, and suppressed cell motility and invasion compared to vehicle or 17-AAG, concomitant with dysregulation of key extracellular matrix proteins such as fibronectin (FN1). Interestingly, while the expression of FN1 was increased by AUY922, FN1 secretion was significantly decreased. This resulted in cytosolic accumulation of FN1 protein within late endosomes, suggesting that AUY922 disrupts vesicular secretory trafficking pathways. Depletion of FN1 by siRNA knockdown markedly reduced the invasive capacity of PCa cells, phenocopying AUY922. These results highlight a novel mechanism of action for AUY922 beyond its established effects on cellular mitosis and survival and, furthermore, identifies extracellular matrix cargo delivery as a potential therapeutic target for the treatment of aggressive PCa.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 13/89
/ 14/19
/ 38/91
/ 82/58
/ Aged
/ Antineoplastic Agents - pharmacology
/ Cytology
/ Explants
/ HSP90 Heat-Shock Proteins - antagonists & inhibitors
/ HSP90 Heat-Shock Proteins - metabolism
/ Humanities and Social Sciences
/ Humans
/ Male
/ Mitosis
/ Prostatic Neoplasms - metabolism
/ Prostatic Neoplasms - pathology
/ Science
/ Secretory Pathway - drug effects
/ siRNA
